Travere Therapeutics Inc logo

TVTX

Travere Therapeutics Inc

$8.2

Earnings Summary

Revenue
$37.1Mn
Net Profits
$150.74Mn
Net Profit Margins
406.35%

Highlights

Revenue:

Travere Therapeutics Inc’s revenue fell -30.66% since last year same period to $37.1Mn in the Q3 2023. On a quarterly growth basis, Travere Therapeutics Inc has generated -37.86% fall in its revenue since last 3-months.

Net Profits:

Travere Therapeutics Inc’s net profit jumped 316.4% since last year same period to $150.74Mn in the Q3 2023. On a quarterly growth basis, Travere Therapeutics Inc has generated 276.03% jump in its net profits since last 3-months.

Net Profit Margins:

Travere Therapeutics Inc’s net profit margin jumped 412.08% since last year same period to 406.35% in the Q3 2023. On a quarterly growth basis, Travere Therapeutics Inc has generated 383.29% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Travere Therapeutics Inc post its latest quarter earnings

EPS Estimate Current Quarter
-0.94
EPS Estimate Current Year
-0.94

Highlights

EPS Estimate Current Quarter:

Travere Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.94 - a 23% jump from last quarter’s estimates.

EPS Estimate Current Year:

Travere Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.94.

Key Ratios

Key ratios of the Travere Therapeutics Inc post its Q4 2023 earnings

Earning Per Share (EPS)
-1.03

Highlights

Earning Per Share (EPS):

Travere Therapeutics Inc’s earning per share (EPS) jumped 0% since last year same period to -1.03 in the Q4 2023. This indicates that the Travere Therapeutics Inc has generated 0% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2023-08-03
-1.16
-1.13
2.59%
2023-05-04
-1.17
-1.27
-8.55%
2023-11-07
-0.14
-1.17
-735.71%
2024-02-15
-1.22
-1.03
15.57%